Product NDC: | 61314-245 |
Proprietary Name: | Betaxolol Hydrochloride |
Non Proprietary Name: | Betaxolol Hydrochloride |
Active Ingredient(s): | 5.6 mg/mL & nbsp; Betaxolol Hydrochloride |
Administration Route(s): | OPHTHALMIC |
Dosage Form(s): | SOLUTION/ DROPS |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 61314-245 |
Labeler Name: | Falcon Pharmaceuticals, Ltd. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019270 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 20000515 |
Package NDC: | 61314-245-03 |
Package Description: | 10 mL in 1 BOTTLE, PLASTIC (61314-245-03) |
NDC Code | 61314-245-03 |
Proprietary Name | Betaxolol Hydrochloride |
Package Description | 10 mL in 1 BOTTLE, PLASTIC (61314-245-03) |
Product NDC | 61314-245 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Betaxolol Hydrochloride |
Dosage Form Name | SOLUTION/ DROPS |
Route Name | OPHTHALMIC |
Start Marketing Date | 20000515 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | Falcon Pharmaceuticals, Ltd. |
Substance Name | BETAXOLOL HYDROCHLORIDE |
Strength Number | 5.6 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |